Small molecule probes to target the human Mediator complex.

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Israel Journal of Chemistry

• Publication date

  2013-08-01

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1002/IJCH.201300039PMID 25705053PMCID PMC4334163
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The Mediator complex and transcription elongation.

  2013cited by this paper
• Using a Fragment-Based Approach To Target Protein–Protein Interactions

  2013cited by this paper
• Transcriptional regulation and its misregulation in disease.

  2013cited by this paper
• Fragment-based approaches in drug discovery and chemical biology.

  2012cited by this paper
• Diastereoselective 1,3-dipolar cycloaddition of pyrylium ylides with chiral enamides.

  2012cited by this paper
• Unraveling framework of the ancestral Mediator complex in human diseases.

  2012cited by this paper
• The future of medicinal chemistry.

  2012cited by this paper
• A structural perspective on Mediator function.

  2012cited by this paper
• Mediator and SAGA have distinct roles in Pol II preinitiation complex assembly and function.

  2012cited by this paper
• Structure of the Mediator Head module bound to the carboxy-terminal domain of RNA polymerase II

  2012cited by this paper
• Structure of the Mediator head module

  2012cited by this paper
• Structure of the stapled p53 peptide bound to Mdm2.

  2012cited by this paper
• Hallmarks of cancer: the next generation.

  2011cited by this paper
• Architecture of the Mediator head module

  2011cited by this paper
• The acidic transcription activator Gcn4 binds the mediator subunit Gal11/Med15 using a simple protein interface forming a fuzzy complex.

  2011cited by this paper
• Function and regulation of the Mediator complex.

  2011cited by this paper
• Molecular Architecture of the Human Mediator–RNA Polymerase II–TFIIF Assembly

  2011cited by this paper
• Mediator and post-recruitment regulation of RNA polymerase II

  2011cited by this paper
• Transient-state Kinetic Analysis of Transcriptional Activator·DNA Complexes Interacting with a Key Coactivator*

  2011cited by this paper
• Structure and VP16 binding of the Mediator Med25 activator interaction domain

  2011cited by this paper
• Mini review: protein-protein interactions in transcription: a fertile ground for helix mimetics.

  2011cited by this paper
• Stabilized helical peptides: overview of the technologies and therapeutic promises

  2011cited by this paper
• Design and structure of stapled peptides binding to estrogen receptors.

  2011cited by this paper
• Interactions between subunits of the Mediator complex with gene-specific transcription factors.

  2011cited by this paper
• Mediator and human disease.

  2011cited by this paper
• The human Mediator complex: a versatile, genome-wide regulator of transcription.

  2010cited by this paper
• Activator-Mediator binding regulates Mediator-cofactor interactions

  2010cited by this paper
• Using peptides to study protein-protein interactions.

  2010cited by this paper
• The metazoan Mediator co-activator complex as an integrative hub for transcriptional regulation

  2010cited by this paper
• A complex task? Direct modulation of transcription factors with small molecules.

  2010cited by this paper
• p53 activates transcription by directing structural shifts within Mediator

  2010cited by this paper
• Structure of the VP16 Transactivator Target in ARC/Mediator

  2010cited by this paper
• Mechanism of Mediator Recruitment by Tandem Gcn4 Activation Domains and Three Gal11 Activator-Binding Domains

  2010cited by this paper
• Complexity in Transcription Control at the Activation Domain–Mediator Interface

  2009cited by this paper
• Wrenchnolol derivative optimized for gene activation in cells.

  2009cited by this paper
• Direct inhibition of the NOTCH transcription factor complex

  2009cited by this paper
• Amphipathic small molecules mimic the binding mode and function of endogenous transcription factors.

  2009cited by this paper
• Activator Gcn4 Employs Multiple Segments of Med15/Gal11, Including the KIX Domain, to Recruit Mediator to Target Genes in Vivo*♦

  2009cited by this paper
• Targeting protein-protein interactions for therapeutic intervention: a challenge for the future.

  2009cited by this paper
• Diversity-oriented synthesis; a spectrum of approaches and results.

  2008cited by this paper
• Drug-like inhibitors of protein-protein interactions: a structural examination of effective protein mimicry.

  2008cited by this paper
• Assessing the permissiveness of transcriptional activator binding sites.

  2008cited by this paper
• ABT-263: a potent and orally bioavailable Bcl-2 family inhibitor.

  2008cited by this paper
• Reaching for high-hanging fruit in drug discovery at protein–protein interfaces

  2007cited by this paper
• Reactivation of the p53 Tumor Suppressor Pathway by a Stapled p53 Peptide

  2007cited by this paper
• Design and synthesis of alpha-helical peptides and mimetics.

  2007cited by this paper
• Synthesis of diverse lactam carboxamides leading to the discovery of a new transcription-factor inhibitor.

  2007cited by this paper
• Reactivation of the p53 tumor suppressor pathway by a stapled p53 peptide.

  2007cited by this paper
• Design and synthesis of α-helical peptides and mimetics

  2007cited by this paper
• Studies leading to potent, dual inhibitors of Bcl-2 and Bcl-xL.

  2007cited by this paper
• An ARC/Mediator subunit required for SREBP control of cholesterol and lipid homeostasis

  2006cited by this paper
• A mechanism for coordinating chromatin modification and preinitiation complex assembly.

  2006cited by this paper
• Mediator as a General Transcription Factor*

  2006cited by this paper
• beta-Peptides as inhibitors of protein-protein interactions.

  2005cited by this paper
• β-Peptides as inhibitors of protein–protein interactions

  2005cited by this paper
• Stereochemical promiscuity in artificial transcriptional activators.

  2005cited by this paper
• In Vivo Activation of the p53 Pathway by Small-Molecule Antagonists of MDM2

  2004cited by this paper
• Pseudo-peptides in drug discovery

  2004cited by this paper
• Activation of Apoptosis in Vivo by a Hydrocarbon-Stapled BH3 Helix

  2004cited by this paper
• Structure and function of CRSP/Med2; a promoter-selective transcriptional coactivator complex.

  2004cited by this paper
• A small molecule transcriptional activation domain.

  2004cited by this paper
• Small molecule transcription factor mimic.

  2004cited by this paper
• CBP and p300: HATs for different occasions.

  2004cited by this paper
• A Gene-Expression Inhibitor that Targets an α-Helix-Mediated Protein Interaction

  2003cited by this paper
• Targeting the transcriptional machinery with unique artificial transcriptional activators.

  2003cited by this paper
• Activation domain–mediator interactions promote transcription preinitiation complex assembly on promoter DNA

  2003cited by this paper
• A gene-expression inhibitor that targets an alpha-helix-mediated protein interaction.

  2003cited by this paper
• Helix-stabilized cyclic peptides as selective inhibitors of steroid receptor–coactivator interactions

  2003cited by this paper
• Discovery of an inhibitor of a transcription factor using small molecule microarrays and diversity-oriented synthesis.

  2003cited by this paper
• Structure, Function, and Activator-Induced Conformations of the CRSP Coactivator

  2002cited by this paper
• Dissecting glucose signalling with diversity-oriented synthesis and small-molecule microarrays

  2002cited by this paper
• Transcription Control by E1A and MAP Kinase Pathway via Sur2 Mediator Subunit

  2002cited by this paper
• Transcription factors as targets for cancer therapy

  2002cited by this paper
• TFIID and human mediator coactivator complexes assemble cooperatively on promoter DNA.

  2002cited by this paper
• The TRAP100 component of the TRAP/Mediator complex is essential in broad transcriptional events and development

  2002cited by this paper
• The druggable genome

  2002cited by this paper
• Transcription coactivator TRAP220 is required for PPAR gamma 2-stimulated adipogenesis.

  2002cited by this paper
• Transcription coactivator TRAP220 is required for PPARγ2-stimulated adipogenesis

  2002cited by this paper
• Human disease genes

  2001cited by this paper
• Target-oriented and diversity-oriented organic synthesis in drug discovery.

  2000cited by this paper
• An All-Hydrocarbon Cross-Linking System for Enhancing the Helicity and Metabolic Stability of Peptides

  2000cited by this paper
• Involvement of the TRAP220 component of the TRAP/SMCC coactivator complex in embryonic development and thyroid hormone action.

  2000cited by this paper
• Ligand-dependent transcription activation by nuclear receptors requires the DRIP complex

  1999cited by this paper
• Mammalian Srb/Mediator complex is targeted by adenovirus E1A protein

  1999cited by this paper
• Peptides as drugs.

  1999cited by this paper
• Identity between TRAP and SMCC complexes indicates novel pathways for the function of nuclear receptors and diverse mammalian activators.

  1999cited by this paper
• The transcriptional cofactor complex CRSP is required for activity of the enhancer-binding protein Sp1

  1999cited by this paper
• Forming stable helical peptides using natural and artificial amino acids

  1999cited by this paper
• Composite co-activator ARC mediates chromatin-directed transcriptional activation

  1999cited by this paper
• Dissecting the regulatory circuitry of a eukaryotic genome.

  1998cited by this paper
• Mammalian mediator of transcriptional regulation and its possible role as an end-point of signal transduction pathways.

  1998cited by this paper
• Transcription factors in disease.

  1996cited by this paper
• Ligand induction of a transcriptionally active thyroid hormone receptor coactivator complex.

  1996cited by this paper
• Association of an activator with an RNA polymerase II holoenzyme.

  1995cited by this paper
• A multiprotein mediator of transcriptional activation and its interaction with the C-terminal repeat domain of RNA polymerase II.

  1994cited by this paper
• Transformation by activated ras or fos prevents myogenesis by inhibiting expression of MyoD1.

  1989cited by this paper
• MyoD1: a nuclear phosphoprotein requiring a Myc homology region to convert fibroblasts to myoblasts.

  1988cited by this paper
• Transcription in yeast activated by a putative amphipathic α helix linked to a DNA binding unit

  1987cited by this paper
• Transcription in yeast activated by a putative amphipathic alpha helix linked to a DNA binding unit.

  1987cited by this paper
• Seminars in Cell & Developmental Biology

  year unknowncited by this paper

• A homozygous MED11 C-terminal variant causes a lethal neurodegenerative disease

  2022cites this paper
• Twenty years of Mediator complex structural studies

  2019cites this paper
• Therapeutic potential of Mediator complex subunits in metabolic diseases.

  2018cites this paper
• SILAC-MS Profiling of Reconstituted Human Chromatin Platforms for the Study of Transcription and RNA Regulation.

  2018cites this paper
• The complex structure and function of Mediator

  2017cites this paper
• The Mediator complex: a central integrator of transcription

  2015cites this paper
• The Mediator complex and transcription regulation

  2013cites this paper